Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice-Reference-Cited by-同舟云学术

Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice

Published:2010-06 Issue:6 Volume:28 Page:1243-1251
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Amiri Farhad,Ko Eun A,Javeshghani Danesh,Reudelhuber Timothy L,Schiffrin Ernesto L

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference43 articles.

1. State-of-the-art lecture. Role of endothelin-1 in hypertension;Schiffrin;Hypertension,1999

2. A novel potent vasoconstrictor peptide produced by vascular endothelial cells;Yanagisawa;Nature,1988

3. Polar secretion of endothelin-1 by cultured endothelial cells;Wagner;J Biol Chem,1992

4. Pathophysiology of endothelin in the cardiovascular system;Miyauchi;Annu Rev Physiol,1999

5. Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1;Shindo;J Mol Med,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aprocitentan. Dual endothelin ETA/ETB receptor antagonist, Treatment of resistant hypertension;Drugs of the Future;2021

2. Effects of the Dual Endothelin Receptor Antagonist Aprocitentan on Body Weight and Fluid Homeostasis in Healthy Subjects on a High Sodium Diet;Clinical Pharmacology & Therapeutics;2020-09-29

3. Role of Inflammation in Microvascular Damage;Updates in Hypertension and Cardiovascular Protection;2020

4. Smooth Muscle Cell–Specific Disruption of the BBSome Causes Vascular Dysfunction;Hypertension;2019-10

5. Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension;Journal of Pharmacology and Experimental Therapeutics;2019-01-08